Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer

Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer

Abstract Background Many patients with incurable esophageal cancer (ECa) present with dysphagia as their predominant symptom. Currently there is no consensus on how best to initially manage this scenario with multiple therapeutic options available. We aimed to assess the safety and efficacy of using...

Full description

Bibliographic Details
Main Authors: Swetha Sridharan, Fiona Day, Jasmin Loh, James Lynam, Joanne Smart, Brandan Holt, Hiren Mandaliya, Anthony Bonaventura, Mahesh Kumar, Jarad Martin
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Radiation Oncology
Subjects:
Hypofractionated
Chemoradiotherapy
Esophageal cancer
Dysphagia
Pallative
Efficacy
Online Access:https://doi.org/10.1186/s13014-022-02127-x

Internet

https://doi.org/10.1186/s13014-022-02127-x

Similar Items